The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
The global gene therapy market is experiencing rapid expansion, driven by advancements in CRISPR and viral vectors. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results